Prognostic correlation analysis of colorectal cancer patients based on monocyte to lymphocyte ratio and folate receptor-positive circulating tumor cells and construction of a machine learning survival prediction models
- PMID: 40376588
- PMCID: PMC12078166
- DOI: 10.3389/fonc.2025.1531836
Prognostic correlation analysis of colorectal cancer patients based on monocyte to lymphocyte ratio and folate receptor-positive circulating tumor cells and construction of a machine learning survival prediction models
Abstract
Purpose: To evaluate the prognostic value of the monocyte to lymphocyte ratio (MLR) and folate receptor-positive circulating tumor cells (FR+CTCs) in patients with colorectal cancer (CRC) and to develop predictive model for post-treatment survival using machine learning (ML) algorithms.
Methods: We retrospectively analyzed 67 CRC patients treated with radical surgery or chemoradiotherapy at The Central Hospital of Wuhan from January 2020 to December 2022. MLR, neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR) and FR+CTCs were categorized into high and low groups and clinicopathologic features were compared. Progression-Free Survival (PFS) and Overall Survival (OS) were analyzed using COX analysis and the Kaplan-Meier survival curve. Three ML algorithms, namely, random forest (RF), support vector machine (SVM), and logistic regression (LR), were utilized to construct the predictive models, and their performance metrics including accuracy, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), precision, recall, F1 value, AUC, and calibration curve were compared.
Results: MLR, FR+ CTCs, and T stage independently predicted PFS (P<0.05), both higher MLR and FR+CTCs levels indicating a significantly shorter PFS (P=0.004). The T stage was the only factor predictive of OS (P=0.043). NLR and PLR did not show significant prognostic effects on PFS or OS (P > 0.05). The RF model demonstrated superior performance with an accuracy of 0.63, sensitivity of 0.69, PPV of 0.75, a precision of 0.43, a recall of 0.5, and an F1 value of 0.43, outperforming the other models.
Conclusion: High MLR and high FR+CTCs are associated with a poorer PFS in CRC patients, suggesting their utility in prognostic assessment. NLR and PLR did not show significant prognostic value in this study. The RF algorithm-based model showed the best predictive performance for post-radical treatment outcomes in CRC.
Keywords: colorectal cancer; folate receptor-positive circulating tumor cells (FR+CTCs); machine learning (ML); monocyte to lymphocyte ratio (MLR); prediction model; prognostic.
Copyright © 2025 Pan, Lu, Lu and Zhang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?Clin Transplant. 2018 Sep;32(9):e13359. doi: 10.1111/ctr.13359. Epub 2018 Aug 26. Clin Transplant. 2018. PMID: 30053318
-
Circulating tumor cells and neutrophil-lymphocyte ratio are predictive markers for metastatic colorectal cancer patients.Transl Cancer Res. 2021 Jan;10(1):288-297. doi: 10.21037/tcr-20-2032. Transl Cancer Res. 2021. PMID: 35116260 Free PMC article.
-
The prognostic value of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in colorectal cancer and colorectal anastomotic leakage patients: a retrospective study.BMC Surg. 2025 Feb 5;25(1):57. doi: 10.1186/s12893-024-02708-5. BMC Surg. 2025. PMID: 39910526 Free PMC article.
-
Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta-analysis.Front Oncol. 2022 May 16;12:734948. doi: 10.3389/fonc.2022.734948. eCollection 2022. Front Oncol. 2022. PMID: 35651788 Free PMC article.
-
Prognostic value of inflammatory markers NLR, PLR, and LMR in gastric cancer patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review.Front Immunol. 2024 Jul 10;15:1408700. doi: 10.3389/fimmu.2024.1408700. eCollection 2024. Front Immunol. 2024. PMID: 39050856 Free PMC article.
Cited by
-
Prognostic value of inflammatory markers and different treatment regimens in neuroendocrine cervical carcinoma: a retrospective study.Front Pharmacol. 2025 Aug 1;16:1652092. doi: 10.3389/fphar.2025.1652092. eCollection 2025. Front Pharmacol. 2025. PMID: 40822489 Free PMC article.
References
LinkOut - more resources
Full Text Sources